Vaccinex Incorporated Pages on BioPortfolio:

Results from other life science and pharmaceutical sites:

BioSpace - Vaccinex, Inc. News, Search Jobs, Events
Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery ... Vaccinex, Inc. Announces Antibody Development and
Commercialization ...
http://www.biospace.com/company_profile.aspx?CompanyId=40310...

Vaccinex, Inc. Announces Award of Key Patent in Europe for its ...
30 /PRNewswire/ -- Vaccinex, Inc. announced today the award of a key European patent (European Patent No. 1340088) for its antibody discovery technology ...
http://www.biospace.com/news_story.aspx?NewsEntityId=79038...

Business Alliances - Research Alliances - James P Wilmot Cancer ...
Vaccinex, Inc., was founded in 1997 by URMC scientists, Maurice Zauderer, Ph.D. and Deepak Sahasrabudhe, M.D., to develop immune system based treatments to ...
http://www.urmc.rochester.edu/cancer-center/researchers/rese...

{1} And Biocon To Co-Develop Antibody Pr - News, Search Jobs ...
18 /PRNewswire/ -- Vaccinex, Inc. and Biocon Limited today announced a broad strategic partnership to discover and co-develop at least four therapeutic ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1818582...

Alliance Vaccinex
Lonza Biologics (Lonza) and Vaccinex, Inc. today announced a strategic alliance that offers their respective clients a broad range of antibody discovery and ...
http://www.lonza.com/group/en/company/news/archive/2003/lonz...

Vaccinex Antibody Licensed to GlaxoSmithKline
About Vaccinex Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human monoclonal antibodies and other biologics to
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Connections: The University of Rochester and the Community
Vaccinex, Inc., president and CEO Maurice Zauderer, right, at work in an immunology lab. Zauderer—associate professor of oncology in microbiology and ...
http://www.rochester.edu/aboutus/connections/development.htm...

BioWorld Today
28 Feb 2007 ... The potential multiple-sclerosis application of Vaccinex Inc.'s preclinical antibody VX15 drew interest from Teva Pharmaceuticals Inc., ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.